TYK2 and psoriasis: TYK2 may play a protective role in the gut, which should be carefully considered in clinical trials, especially in patients with active enteritis; however, the recent TYK2 inhibitor trial in psoriasis did not report an increased risk of gut-related adverse events in comparison with placebo (54).